Intravenous glutathione treatment has been shown to be beneficial for conditions such Parkinson's disease, heavy metal chelation, and reduction of neuropathy from platin chemotherapy drugs
First-generation copper peptides, second-generation SRCP formulations, various ratios of peptide to copper, synthetic versus naturally occurring variants, each designed for specific applications that most guides fail to distinguish
(1981) published in European Neurology administered DSIP as a slow intravenous infusion at 25 nmol/kg to six healthy volunteers in a double-blind crossover design
Most patients master the technique quickly
Id suggest peptide use and even micro dosing anti-aging meds is here aplenty already the half lives of these things is so short as Joel Filliol once put it Long Distance anti-doping is an IQ test
Because of rare thyroid tumours seen in animal studies, these drugs are avoided in people with a history of medullary thyroid carcinoma or MEN2